• Home
  • Leadership
    • Management Team
    • Advisors
    • Scientific Advisory Board
    • Board of Directors
  • Therapeutic Programs
  • Media
  • Contact
GeneVentiv Announces Appointment to Scientific Advisory Board

GeneVentiv Announces Appointment to Scientific Advisory Board

by Damon Race | Jan 19, 2021 | Press

January 12, 2021 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a gene therapy company developing a safe, effective and durable, single infusion treatment for all types of hemophilia with or without inhibitors, today announced the...

Recent Posts

  • GeneVentiv Invited to Present at BioPharm America 2023
  • Rare Disease Advisor – An Interview with Damon Race, President and CEO of GeneVentiv Therapeutics
  • GeneVentiv Welcomes New Advisors
  • GeneVentiv Invited to Present in Labcorp’s Symposium at the 26th Annual Meeting of the American Society of Cell and Gene Therapy
  • GeneVentiv Invited to Present at The National Hemophilia Foundation’s 17th Workshop

Recent Comments

    Archives

    • August 2023
    • April 2023
    • February 2023
    • January 2023
    • September 2022
    • June 2022
    • March 2022
    • February 2022
    • November 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020

    Categories

    • In the News
    • Press
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    • Please prove you are human by selecting the Heart.
    • This field is for validation purposes and should be left unchanged.

    Copyright © 2020 GeneVentiv Therapeutics. All rights reserved.